|
EXT2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.697600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.480000E-02 |
| Normal-vs-Stage2 |
5.012600E-01 |
| Normal-vs-Stage3 |
1.210060E-02 |
| Normal-vs-Stage4 |
2.488200E-02 |
| Stage1-vs-Stage2 |
4.155600E-01 |
| Stage1-vs-Stage3 |
1.752370E-01 |
| Stage1-vs-Stage4 |
3.645000E-01 |
| Stage2-vs-Stage3 |
1.145390E-01 |
| Stage2-vs-Stage4 |
1.786960E-01 |
| Stage3-vs-Stage4 |
8.935800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.094200E-02 |
| Normal-vs-AfricanAmerican |
2.890400E-01 |
| Normal-vs-Asian |
4.257800E-01 |
| Caucasian-vs-AfricanAmerican |
7.596000E-01 |
| Caucasian-vs-Asian |
3.009200E-01 |
| AfricanAmerican-vs-Asian |
6.566600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.856000E-02 |
| Normal-vs-Female |
4.445700E-02 |
| Male-vs-Female |
6.205600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.163360E-01 |
| Normal-vs-Age(41-60Yrs) |
3.720100E-02 |
| Normal-vs-Age(61-80Yrs) |
4.968300E-02 |
| Normal-vs-Age(81-100Yrs) |
5.785500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.740600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.585000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.292800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.744200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.308000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.922600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.517440E-01 |
| Classical-VS-Follicular |
4.461800E-03 |
| Classical-VS-Other |
3.735800E-01 |
| Classical-VS-Normal |
2.341400E-01 |
| Tall-VS-Follicular |
7.022400E-01 |
| Tall-VS-Other |
8.838000E-01 |
| Tall-VS-Normal |
4.455600E-02 |
| Follicular-VS-Other |
9.432400E-01 |
| Follicular-VS-Normal |
4.800100E-03 |
| Other-VS-Normal |
1.924390E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.487560E-02 |
| Normal-vs-N1 |
2.816100E-03 |
| N0-vs-N1 |
1.930850E-01 |
|
|
